FDA.reportPublic FDA data

Tenofovir Disoproxil Fumarate

Product NDC
67184-0520
11-digit product format
671840520
Labeler code
67184
Product ID
67184-0520_ec0e46de-c8b5-371b-e053-2995a90a9f95
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Tenofovir Disoproxil Fumarate
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Qilu Pharmaceutical Co., Ltd.
Application
ANDA209498
Marketing category
ANDA
Marketing start
2020-01-01
Marketing end
0000-00-00
Substance
TENOFOVIR DISOPROXIL FUMARATE
Active strength
250 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
33cd1557-9629-1a35-1f2f-499cf7c608bcProduct name220260305
5f93de8c-a439-4aaa-862f-7cf2524cb240Product name320250812
6286e356-28a5-4b4b-a174-76bf53b211e3Product name620250121
233e3f87-da6c-4b7d-80cb-963ca3258270Product name220240419
c0c98dbe-5e23-74e9-f9fc-07af05f77d95Product name820240319
4ef90d80-1289-4267-a2bb-01c741d1208fProduct name120230829
72dcca4e-6eae-4149-a92b-264c2a07004fProduct name120230808
1cd1fd33-94db-4c45-bd26-82773ea350a3Product name220220317
14397d46-1c8c-bbf7-f4b7-5a7e59d3690fProduct name420220314
320f244d-8b4e-4893-9f14-104b2a8e0aafProduct name220201007
7ff71f22-5b66-4a3d-bf64-671893a6409dProduct name220201007
6f122144-2ceb-48fa-a906-0d2eb742717eProduct name120190624
8051c8a3-aee0-45a2-a236-8ee3f9e65f67Product name120181211
a56d673d-fa42-4b0e-b5ce-e65a5eab34b7Product name120180911
d1784558-3c5f-4d73-8a7c-051102bb6c92Product name120160405
7fd46899-3505-4ed4-b856-6b2509a76004Product name120151123
0583b5e6-2e6e-c94b-9ff6-81a81ba199deProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67184-0520-1Tenofovir Disoproxil Fumarate30 in 1 BOTTLE, PLASTICTABLET, COATED3011
67184-0520-2Tenofovir Disoproxil Fumarate300 in 1 BOTTLE, PLASTICTABLET, COATED30011

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67184-0520TENOFOVIR DISOPROXIL FUMARATE TABLET, COATED [QILU PHARMACEUTICAL CO., LTD.]11Legacy NDC, 2 package rows20221029_b43a3cae-059e-4af8-8fcf-07a597e57f0d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1243328tenofovir disoproxil fumarate 200 MG Oral TabletPSNb43a3cae-059e-4af8-8fcf-07a597e57f0d11
1243227tenofovir disoproxil fumarate 250 MG Oral TabletPSNb43a3cae-059e-4af8-8fcf-07a597e57f0d11
349251tenofovir disoproxil fumarate 300 MG Oral TabletPSNb43a3cae-059e-4af8-8fcf-07a597e57f0d11
1243328tenofovir disoproxil fumarate 200 MG Oral TabletSCDb43a3cae-059e-4af8-8fcf-07a597e57f0d11
1243227tenofovir disoproxil fumarate 250 MG Oral TabletSCDb43a3cae-059e-4af8-8fcf-07a597e57f0d11
349251tenofovir disoproxil fumarate 300 MG Oral TabletSCDb43a3cae-059e-4af8-8fcf-07a597e57f0d11
1243328tenofovir disoproxil fumarate 200 MG (equivalent to tenofovir disoproxil 163 MG) Oral TabletSYb43a3cae-059e-4af8-8fcf-07a597e57f0d11
1243227tenofovir disoproxil fumarate 250 MG (equivalent to tenofovir disoproxil 204 MG) Oral TabletSYb43a3cae-059e-4af8-8fcf-07a597e57f0d11
349251tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSYb43a3cae-059e-4af8-8fcf-07a597e57f0d11

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
67184-0520-16718405200130 TABLET, COATED in 1 BOTTLE, PLASTIC (67184-0520-1) 2020-01-010000-00-00NoNoCurrent
67184-0520-267184052002300 TABLET, COATED in 1 BOTTLE, PLASTIC (67184-0520-2) 2020-01-010000-00-00NoNoCurrent